These were some of the sudden symptoms Lia Pinelli described to her doctor in August ... Stelo, by Dexcom, was approved for ...
8h
The Times of India hosted Medithon-3, a conference dedicated to raising diabetes awareness and promoting early detection.
A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback